ADC Therapeutics (ADCT) Short Interest Ratio & Short Volume → My system predicted the BA collapse – now it’s issuing an AI warning (From Chaikin Analytics) (Ad) Free ADCT Stock Alerts $3.99 -0.20 (-4.77%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ADC Therapeutics Short Interest DataCurrent Short Volume857,600 sharesPrevious Short Volume888,100 sharesChange Vs. Previous Month-3.43%Dollar Volume Sold Short$3.77 millionShort Interest Ratio / Days to Cover1.3Last Record DateApril 30, 2024Outstanding Shares82,780,000 sharesFloat Size59,820,000 sharesShort Percent of Float1.43%Today's Trading Volume638,510 sharesAverage Trading Volume738,191 sharesToday's Volume Vs. Average86% Short Selling ADC Therapeutics ? Sign up to receive the latest short interest report for ADC Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADCT Short Interest Over TimeADCT Days to Cover Over TimeADCT Percentage of Float Shorted Over Time Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. ADC Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024857,600 shares $3.77 million -3.4%1.4%1.3 $4.40 4/15/2024888,100 shares $3.87 million -10.6%1.6%1.2 $4.36 3/31/2024993,100 shares $4.46 million +5.7%1.8%1.3 $4.49 3/15/2024939,800 shares $3.55 million +8.2%1.7%1.2 $3.78 2/29/2024868,800 shares $4.20 million -39.2%1.6%0.9 $4.83 2/15/20241,430,000 shares $7.11 million -51.2%2.7%1.5 $4.97 Get the Latest News and Ratings for ADCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ADC Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,930,000 shares $9.17 million -12.8%5.4%3.5 $3.13 1/15/20243,360,000 shares $7.16 million -9.7%6.2%5 $2.13 12/31/20233,720,000 shares $6.18 million -8.2%6.8%6.1 $1.66 12/15/20234,050,000 shares $6.70 million -1.0%7.3%7.8 $1.66 11/30/20234,090,000 shares $3.49 million +13.0%7.7%12.3 $0.85 11/15/20233,620,000 shares $2.10 million -8.8%6.8%12.2 $0.58 10/31/20233,970,000 shares $2.78 million -23.7%7.5%14.6 $0.70 10/15/20235,200,000 shares $4.16 million -1.7%9.8%17.1 $0.80 9/30/20235,290,000 shares $4.75 million +3.1%9.9%11.7 $0.90 9/15/20235,130,000 shares $4.26 million +0.4%9.6%10.8 $0.83 8/31/20235,110,000 shares $6.18 million -4.0%8.1%11.1 $1.21 8/15/20235,320,000 shares $8.49 million -13.6%8.5%11.5 $1.60 7/31/20236,160,000 shares $9.15 million +4.1%9.8%11.9 $1.49 7/15/20235,920,000 shares $8.94 million -3.7%9.4%11.8 $1.51 6/30/20236,150,000 shares $13.25 million +1.2%9.8%13.1 $2.16 6/15/20236,080,000 shares $14.08 million +0.2%9.7%12.5 $2.32 5/31/20236,070,000 shares $14.26 million -1.5%9.7%10.9 $2.35 5/15/20236,160,000 shares $16.32 million -17.1%9.8%10.1 $2.65 4/30/20237,430,000 shares $14.41 million +1.5%11.5%13.1 $1.94 4/15/20237,320,000 shares $15.96 million +5.5%11.3%12.8 $2.18 3/31/20236,940,000 shares $13.53 million -2.9%10.8%10.7 $1.95 3/15/20237,150,000 shares $17.30 million +5.3%11.1%8.3 $2.42 2/28/20236,790,000 shares $24.44 million +1.2%10.5%8.2 $3.60 2/15/20236,710,000 shares $29.73 million -4.3%10.5%8.5 $4.43 1/31/20237,010,000 shares $35.82 million -0.7%11.1%7.9 $5.11 1/15/20237,060,000 shares $35.30 million -6.6%14.6%8.2 $5.00 12/30/20227,560,000 shares $29.03 million +4.9%15.6%9.5 $3.84 12/15/20227,210,000 shares $23.94 million -0.6%14.9%10.6 $3.32 11/30/20227,250,000 shares $26.54 million +16.4%16.0%18.6 $3.66 11/15/20226,230,000 shares $27.47 million -4.3%13.7%18.4 $4.41 10/31/20226,510,000 shares $28.90 million +0.3%14.4%26.4 $4.44 10/15/20226,490,000 shares $30.50 million +1.7%14.3%27.9 $4.70 9/30/20226,380,000 shares $30.75 million -0.6%15.0%24.5 $4.82 9/15/20226,420,000 shares $34.92 million -3.0%15.1%23.1 $5.44The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide ADCT Short Interest - Frequently Asked Questions What is ADC Therapeutics' current short interest? Short interest is the volume of ADC Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 857,600 shares of ADCT short. 1.43% of ADC Therapeutics' shares are currently sold short. Learn More on ADC Therapeutics' current short interest. What is a good short interest ratio for ADC Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADCT shares currently have a short interest ratio of 1.0. Learn More on ADC Therapeutics's short interest ratio. Which institutional investors are shorting ADC Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ADC Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ADC Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.43% of ADC Therapeutics' floating shares are currently sold short. Is ADC Therapeutics' short interest increasing or decreasing? ADC Therapeutics saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 857,600 shares, a decline of 3.4% from the previous total of 888,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ADC Therapeutics' float size? ADC Therapeutics currently has issued a total of 82,780,000 shares. Some of ADC Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ADC Therapeutics currently has a public float of 59,820,000 shares. How does ADC Therapeutics' short interest compare to its competitors? 1.43% of ADC Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ADC Therapeutics: Amarin Co. plc (3.94%), Harrow, Inc. (15.55%), Corbus Pharmaceuticals Holdings, Inc. (6.84%), Erasca, Inc. (10.23%), Mereo BioPharma Group plc (2.02%), Rani Therapeutics Holdings, Inc. (10.88%), Terns Pharmaceuticals, Inc. (10.91%), Mersana Therapeutics, Inc. (8.92%), Annexon, Inc. (6.63%), Biomea Fusion, Inc. (50.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ADC Therapeutics stock? Short selling ADCT is an investing strategy that aims to generate trading profit from ADC Therapeutics as its price is falling. ADCT shares are trading down $0.33 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ADC Therapeutics? A short squeeze for ADC Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADCT, which in turn drives the price of the stock up even further. How often is ADC Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADCT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: AMRN Short Squeeze HROW Short Squeeze CRBP Short Squeeze ERAS Short Squeeze MREO Short Squeeze RANI Short Squeeze TERN Short Squeeze MRSN Short Squeeze ANNX Short Squeeze BMEA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:ADCT) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityElon to Transform U.S. Economy? Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing